“The Efficacy of Certolizumab Pegol Re-Treatment on Plaque Psoriasis Following a Blinded Treatment Break: Results from the CIMPACT Trial”. SKIN The Journal of Cutaneous Medicine, vol. 3, no. 2, Mar. 2019, p. 174, https://doi.org/10.25251/skin.3.2.14.